CRIS Current Research Information System

MARZOCCHI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.957
AS - Asia 5.061
EU - Europa 4.710
AF - Africa 434
SA - Sud America 240
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 2
Totale 16.417
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.901
VN - Vietnam 1.582
SG - Singapore 1.272
CN - Cina 1.230
GB - Regno Unito 1.048
DE - Germania 915
IT - Italia 490
SE - Svezia 473
NL - Olanda 442
HK - Hong Kong 320
UA - Ucraina 291
FR - Francia 288
IN - India 232
RU - Federazione Russa 215
IE - Irlanda 179
BR - Brasile 170
JP - Giappone 97
NG - Nigeria 93
TG - Togo 86
SC - Seychelles 82
EE - Estonia 81
CI - Costa d'Avorio 77
ZA - Sudafrica 77
BG - Bulgaria 71
FI - Finlandia 70
KR - Corea 65
CH - Svizzera 55
JO - Giordania 42
PH - Filippine 37
CA - Canada 34
IR - Iran 28
AR - Argentina 27
TH - Thailandia 27
BE - Belgio 24
IQ - Iraq 18
TR - Turchia 16
MX - Messico 15
BD - Bangladesh 14
PL - Polonia 14
TW - Taiwan 13
AU - Australia 11
SA - Arabia Saudita 10
AT - Austria 9
CO - Colombia 9
EC - Ecuador 9
PK - Pakistan 9
CL - Cile 8
ES - Italia 8
ID - Indonesia 8
UZ - Uzbekistan 7
EG - Egitto 6
LT - Lituania 6
PY - Paraguay 6
GR - Grecia 5
MY - Malesia 5
OM - Oman 5
PE - Perù 5
RO - Romania 5
AM - Armenia 3
CZ - Repubblica Ceca 3
HR - Croazia 3
LB - Libano 3
MN - Mongolia 3
SI - Slovenia 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
DK - Danimarca 2
ET - Etiopia 2
HU - Ungheria 2
IL - Israele 2
MA - Marocco 2
MM - Myanmar 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
UY - Uruguay 2
VE - Venezuela 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
FK - Isole Falkland (Malvinas) 1
GT - Guatemala 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
ML - Mali 1
NO - Norvegia 1
PR - Porto Rico 1
Totale 16.412
Salva come PNG Salva come JPEG
Città #
Southend 909
Singapore 885
Ashburn 595
Fairfield 545
Chandler 467
Frankfurt am Main 372
Eygelshoven 337
San Jose 328
Hong Kong 306
Santa Clara 288
Ho Chi Minh City 264
Woodbridge 258
Seattle 256
Hanoi 253
Wilmington 251
Houston 247
Dong Ket 217
Ann Arbor 216
Princeton 209
Jacksonville 199
Cambridge 198
Beijing 176
Dublin 176
Boardman 138
Hefei 126
Abeokuta 92
Padova 92
Westminster 92
Lauterbourg 89
Nanjing 89
Tokyo 87
Lomé 86
Abidjan 76
New York 74
Berlin 73
Turin 70
Bologna 68
Sofia 68
Bremen 66
Los Angeles 59
Helsinki 52
Da Nang 51
Bern 48
Buffalo 45
Jinan 44
Amman 42
Nanchang 40
Seoul 40
Saint Petersburg 39
Milan 37
Changsha 35
Dearborn 35
San Diego 35
Guangzhou 34
Haiphong 34
Shenyang 34
Mülheim 33
Medford 31
Redondo Beach 31
Hebei 30
Munich 30
Shanghai 30
Dallas 28
São Paulo 25
Brussels 23
Mahé 23
The Dalles 23
Falkenstein 22
Paris 22
Tianjin 21
Chicago 20
Olalla 20
Jiaxing 19
Zhengzhou 19
Mountain View 18
Phoenix 18
Turku 18
Lanzhou 16
London 16
Can Tho 15
Taizhou 15
Yubileyny 15
San Francisco 14
Verona 14
Xi'an 14
Düsseldorf 13
Norwalk 13
Orem 13
Thái Nguyên 13
Haikou 12
Ningbo 12
Redwood City 12
Shenzhen 12
Bengaluru 11
Des Moines 11
Hangzhou 11
Hải Dương 11
Biên Hòa 10
Fuzhou 10
Leawood 10
Totale 10.839
Salva come PNG Salva come JPEG
Nome #
[Prevalence of degenerative aortic valve stenosis in the elderly: results of a large community-based epidemiological study] 924
A randomised study comparing the antiplatelet and antinflammatory effect of clopidogrel 150mg/day versus 75mg/day in patients with ST-segment elevation acute myocardial infarction and poor responsiveness to clopidogrel: Results from the DOUBLE study. 269
A Comparison Between Coronary Angioplasty and Coronary Artery Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Stenosis (the Bologna Registry). 260
Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality 253
[Cognitive and quality of life trajectory after either surgical or transcatheter aortic valve replacement in high-risk patients] 249
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome. 247
Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system. 245
A randomised comparison between clopidogrel 150 mg daily maintenance dose versus 75 mg in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention 236
Cognitive functions: Evaluation and changes after transcatheter aortic valve implantation in elderly patients 230
Balloon aortic valvuloplasty as a bridge-to-decision in high risk patients with aortic stenosis: A new paradigm for the heart team decision making 224
Incidence and Outcome of High On-Treatment Platelet Reactivity in Patients With Non-ST Elevation Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the VIP [VerifyNow and Inhibition of Platelet Reactivity] Study) 222
Long-term clinical and angiographic outcome of patients with occlusive in-stent restenosis treated with (32P) beta-brachytherapy. 221
Clinical comparison of "normal-hours" vs "off-hours" percutaneous coronary interventions for ST-elevation myocardial infarction. 220
Causes and timing of death during long-term follow-up after transcatheter aortic valve replacement 216
Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices 214
Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina. 207
Utility of stress perfusion-cardiac magnetic resonance in follow-up of patients undergoing percutaneous coronary interventions of the left main coronary artery 204
32P brachytherapy in the treatment of complex Cypher in-stent restenosis. 203
Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network. 203
Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system 200
Incidence, treatment, and outcome of acute aortic valve regurgitation complicating percutaneous balloon aortic valvuloplasty 200
Brachiterapia coronarica per la ristenosi intrastent a carico di biforcazioni: follow up angiografico a 9 mesi. 196
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and 1-year clinical outcome 195
How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation? 194
Biolimus-A9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography 192
Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. 191
Prognostic Significance of Baseline White Blood Cell Count in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome. 190
Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome. 188
Clinical value of multidetector CT coronary angiography as a preoperative screening test before non-coronary cardiac surgery 186
Predictors of complicated athero-thrombotic lesions in non-ST segment acute coronary syndrome. 184
Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome. 184
The role of percutaneous aortic bloon valvuloplasty for severe degenerative aortic valve stenosis in the modern era of interventional cardiology 183
Impact of a territorial ST-segment elevation myocardial infarction network on prognosis of patients with out-of-hospital cardiac arrest. 183
Elevati livelli pre-procedurali della proteina C-reattiva predicono la mortalita a 9 mesi dall'angioplastica del tronco comune non protetto. 181
La rete per il trattamento dell’infarto miocardico acuto con sopraslivellamento del tratto ST in Italia. Risultati della rilevazione RETE IMA WEB 181
Pre-hospital ECG in patients undergoing primary percutaneous interventions within an integrated system of care: reperfusion times and long-term survival benefits. 179
Clinical imaging of the vulnerable plaque in the coronary arteries: new intracoronary diagnostic methods. 179
TCT-670 Incidence, Treatment And Outcome Of Acute Aortic Valve Regurgitation Complicating Percutaneous Balloon Aortic Valvuloplasty 177
A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged ³ 75 years) 176
The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. 176
Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization 176
Risk of stroke in patients with stable coronary artery disease undergoing percutaneous coronary intervention versus optimal medical therapy: Systematic review and meta-analysis of randomized controlled trials 176
Preprocedural Levels of C-Reactive Protein and Leukocyte Counts Predict 9-Month Mortality After Coronary Angioplasty for the Treatment of Unprotected Left Main Coronary Artery Stenosis. 175
What is the acceptable rate of false positives for STEMI within a primary PCI network? Insights from a metropolitan system with direct ambulance-based access. 174
Is balloon aortic valvuloplasty safe in patients with significant aortic valve regurgitation? 171
Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. 170
One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors: results from a regional cohort study 169
Effective and equivalent organ doses in patients undergoing coronary angiography and percutaneous coronary interventions 169
Usefulness of prehospital triage in patients with cardiogenic shock complicating ST-elevation myocardial infarction treated with primary percutaneous coronary intervention 168
La brachiterapia endocoronarica nei pazienti diabetici con ristenosi intrastent. 168
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneos coronary intervention 166
Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina 166
Early vs. late IIb/IIIa agents administration in primary percutaneous interventions for ST-elevation myocardial infarction: results of a single centre registry 163
Incidence, prognostic value and management of vascular complications with transfemoral transcatheter aortic valve implantation. 161
How should i treat an unexpected deadlock at the time of transcatheter aortic valve prosthesis implantation? 161
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 159
Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients. 159
Long-term effectiveness of early administration of IIb/IIIa agents to high-risk patients undergoing primary percutaneous interventions 158
Left ventricular recovery after ST-elevation myocardial infarction in patients treated with primary coronary angioplasty and abciximab or tirofiban 157
Riduzione del tempo di ritardo terapeutico e della mortalità ospedaliera nei pz con STEMI grazie ad un programma di accesso rapido alla PTCA primaria 155
SHORT AND LONG-TERM PROGNOSTIC SIGNIFICANCE OF ST-SEGMENT ELEVATION IN LEAD AVR IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME 155
Homocysteine-lowering therapy and early progression of transplant vasculopathy: a prospective, randomized, IVUS-based study. 153
Randomized comparison between tirofiban and abcximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abcximab (FATA) in ST-elevation myocardial infarction trial 152
Predictors of 32P h brachytherapy failure in patients with high-risk in-stent restenosis 151
Prognostic significance of mean platelet volume on admission in unselected cohort of patients with non ST-segment elevation acute coronary syndrome 150
Diagnostic performance of standard electrocardiogramfor prediction of site of coronary occlusion in unselected anterior STEMI patients 147
The safety of drug-eluting stents. 145
Acute hand ischemia after radial intervention in patient with CREST-associated pulmonary hypertension: successful treatment with manual thromboaspiration. 145
Transcatheter aortic valve implantation for severe autograft regurgitation after Ross operation. 145
Randomized comparison of balloon aortic valvuloplasty performed with or without rapid cardiac pacing: The pacing versus no pacing (PNP) study 144
Risk of stroke in patients with high on clopidrogel platelet reactivity to ADP after percutaneous coronary intervention: systematic review and meta-analysis 142
Electrocardiographic pattern to enhance prediction of in-hospital cardiovascular death in patients with non ST elevation acute coronary syndrome 142
Predictors of beta-brachytherapy failure in patients with high-risk in-stent restenosis 141
Description of an In-vitro of Stent Perfusion to Study Stent Thrombosis at Different Shear Rates 140
One-year outcome of patients eligible to transcatheter aortic valve implantation according to actual treatment 140
Risk of Adverse Cardiac and Bleeding Events Following Cardiac and Noncardiac Surgery in Patients With Coronary Stent: How Important Is the Interplay Between Stent Type and Time From Stenting to Surgery? 140
Ruolo del fattore tissutale circolante nel determinare la trombosi di stent in un sistema di perfusione in vitro. 138
Preoperative C-reactive protein levels predict 9-month mortality after coronary artery bypass grafting surgery for the treatment of left main coronary artery stenosis. 137
Influence of C-reactive protein on the effectiveness of IIb/IIIa agents in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 137
Ogni lungo viaggio inizia con un piccolo passo: Il Signor C e la cardiologia interventistica 135
Predictors of complicated athero-thrombotic lesions and their prognostic significance in unselected patients with non ST-segment acute coronary syndrome 135
Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with tirofiban or Abciximab [FATA] trial) 130
Significant decrease of door-to-balloon time by direct transport from ambulance to cath lab 130
False Positive Coronary Angiography Activation in a Primary Coronary Angioplasty Network: Does Direct Ambulance-based Access Influence The Prevalence Rate? 128
In the era of the valve-in-valve: is transcatheter aortic valve implantation (TAVI) in sutureless valves feasible? 124
Coronary 32P beta Brachytherapy: our singleinstitution experience 123
Management of acute left ventricular dysfunction after primary percutaneous coronary intervention for ST elevation acute myocardial infarction 120
Left Ventricular Function After ST-Elevation Myocardial Infarction in Patients Treated With Primary Coronary Angioplasty and Abciximab or Tirofiban: Insights From the Facilitated Angioplasty with Tirofiban or Abciximab (FATA) Randomized Trial 120
Valve-in-valve technique to manage acute paraprosthetic leak after transcatheter aortic valve implantation. 114
Displacement of calcium nodules of the native valve as a possible cause of left main occlusion following transcatheter aortic valve implantation. 105
null 86
Emergency balloon aortic valvuloplasty in patients with critical aortic stenosis presenting with cardiogenic shock. 86
null 72
The conundrum of transient cortical blindness following coronary angiography. 61
Totale 16.696
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.904
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.904
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021550 0 0 0 0 0 0 0 0 0 0 62 488
2021/20221.903 251 99 119 173 139 109 29 100 58 151 344 331
2022/20232.280 211 324 136 279 220 154 47 148 396 54 200 111
2023/2024491 35 63 30 58 56 146 17 31 5 26 9 15
2024/20252.049 95 304 172 147 395 80 90 49 25 165 60 467
2025/20265.024 351 410 332 390 510 607 755 187 1.008 395 79 0
Totale 16.696